EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Effectiveness of the QUAD Shot Regimen for Advanced Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Observational Study (Japanese Radiation Oncology Study Group 18-2)

Ryo Toya, Takeshi Kodaira, Yoshio Tamaki, Atsushi Motegi, Takuya Yamazaki, Nobutaka Mizoguchi, Koyo Kikuchi, Natsuo Tomita, Osamu Tanaka, Kazuki Ishikawa, Yasuo Kosugi, Koichi Yasuda und 4 weitere

Practical Radiation Oncology · 2026

DOI: 10.1016/j.prro.2026.03.009 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Practical Radiation Oncology, 2026. Verfasst von Ryo Toya und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Radiation Oncology, F…. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Radiotherapy, Conformal, Radiotherapy, Intensity-Modulated, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The palliative effects of the QUAD shot regimen were prospectively assessed using 3-dimensional conformal radiation therapy (3D-CRT) or intensity modulated radiation therapy (IMRT) for advanced head and neck squamous cell carcinoma. METHODS AND MATERIALS: Fifty patients with stage III to IV head and neck squamous cell carcinoma were enrolled. One cycle consisted of 14 to 14.8 Gy in 4 fractions administered over 2 consecutive days and was repeated up to 3 cycles. Toxicity and quality of life (QOL) were assessed using the National Cancer Institute Common Terminology Criteria for Adverse Events, version 5.0, and the University of Washington QOL Questionnaire, version 4, respectively. RESULTS: Two patients refused treatment prior to the initial cycle, whereas the remaining 48 were included in the analysis. 3D-CRT and IMRT were delivered to 16 (33%) and 32 (67%) patients, respectively. Thirty-nine (81%) patients completed all 3 cycles. Treatment response on physical examination was confirmed in 42 (88%) patients. Radiation therapy-associated grade 3 and 4 toxicities were observed in 4 (8%) and 1 (2%) patients, respectively. Of the 12 domain-specific QOL scores, >50% of patients reported the same or better status across all domains at 3 months. The global QOL scores were well preserved, with >70% of patients reporting the same or better scores, rising to >80% at 3 months. The median overall survival was 8.3 months. Multivariate analysis indicated that a T category < T4 (P = .001) and 3 QUAD shot cycles (P = .004) were significantly associated with improved overall survival. The median progression-free survival was 6.7 months. Multivariate analysis indicated that a T category < T4 (P = .026) and 3 QUAD shot cycles (P = .014) were significantly associated with improved progression-free survival. CONCLUSIONS: The QUAD shot regimen using 3D-CRT or IMRT achieves a high completion rate over 3 cycles, good palliative effects with lower toxicity, and improved or stable QOL. Three cycles are preferred for improved treatment outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedSquamous Cell Carcinoma of Head and NeckAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedProspective StudiesQuality of LifeTreatment OutcomeJapan

Autor:innen und Institutionen

  • Department of Radiological Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Electro…
  • Department of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Department of Radiation Oncology, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Japan.
  • Department of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Department of Radiological Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; Department of Radiation Oncology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • Department of Radiation Oncology, Kanagawa Cancer Center, Yokohama, Japan.

Zitieren

APA

Toya, R., Kodaira, T., Tamaki, Y., Motegi, A., Yamazaki, T., Mizoguchi, N., Kikuchi, K., Tomita, N., Tanaka, O., Ishikawa, K., Kosugi, Y., Yasuda, K., Saitoh, J. I., Murotani, K., Ota, Y., & Akimoto, T. (2026). Effectiveness of the QUAD Shot Regimen for Advanced Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Observational Study (Japanese Radiation Oncology Study Group 18-2). Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2026.03.009

Vancouver

Toya R, Kodaira T, Tamaki Y, Motegi A, Yamazaki T, Mizoguchi N, et al. Effectiveness of the QUAD Shot Regimen for Advanced Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Observational Study (Japanese Radiation Oncology Study Group 18-2). Practical Radiation Oncology. 2026. doi:10.1016/j.prro.2026.03.009

BibTeX
@article{Toya2026,
  author = {Toya, Ryo and Kodaira, Takeshi and Tamaki, Yoshio and Motegi, Atsushi and Yamazaki, Takuya and Mizoguchi, Nobutaka and Kikuchi, Koyo and Tomita, Natsuo and Tanaka, Osamu and Ishikawa, Kazuki and Kosugi, Yasuo and Yasuda, Koichi and Saitoh, Jun-Ichi and Murotani, Kenta and Ota, Yosuke and Akimoto, Tetsuo},
  title = {Effectiveness of the QUAD Shot Regimen for Advanced Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Observational Study (Japanese Radiation Oncology Study Group 18-2)},
  journal = {Practical Radiation Oncology},
  year = {2026},
  doi = {10.1016/j.prro.2026.03.009}
}
Kostenlos starten →